Latest news
Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 13:27:21 GMTExosome application gets U.S. allowance to target Type 1 diabetes autoimmunity - Stock TitanStock Titan · Thu, 06 Aug 2026 13:15:00 GMTbioAffinity Technologies Faces Nasdaq Delisting Risk After Notice - The Globe and MailThe Globe and Mail · Sat, 01 Aug 2026 21:54:00 GMTbioAffinity Technologies Received Notice of Delisting - TradingViewTradingView · Fri, 31 Jul 2026 21:23:01 GMTClean Energy Technologies (Nasdaq: CETY) raises $125,000 via new convertible note - Stock TitanStock Titan · Fri, 31 Jul 2026 21:15:38 GMTSunCar Has 180 Days to Meet Nasdaq's $1 Minimum Bid Rule - Stock TitanStock Titan · Thu, 30 Jul 2026 20:30:00 GMTIWOW Technology Receives Listing Notice for Up to 66.7 Million Shares - marketscreener.commarketscreener.com · Mon, 27 Jul 2026 07:00:00 GMT